Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|October 23, 2021
Vaccines for Non-Viral Cancer PreventionCristina Bayó, Gerhard Jung, Marta Español-Rego, et al.
Frontiers in Immunology|October 14, 2022
Practical aspects of chimeric antigen receptor T-cell administration: From commercial to point-of-care manufacturingNuria Martinez-Cibrian, Marta Español-Rego, Mariona Pascal, et al.
Immunology Letters|November 1, 2019
CART manufacturing process and reasons for academy-pharma collaborationNatalia Egri, Iñaki Ortiz de Landazuri, Clara San Bartolomé, et al.
Frontiers in Immunology|April 30, 2019
Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological InvestigationsRaquel Ruiz-García, Eugenia Martínez-Hernández, Milagros García-Ormaechea, et al.
Frontiers in Immunology|April 12, 2017
Disease Phenotype and Outcome Depending on the Age at Disease Onset in Patients Carrying the R92Q Low-Penetrance Variant in <i>TNFRSF1A</i> GeneEstíbaliz Ruiz-Ortiz, Estíbaliz Iglesias, Alessandra Soriano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2025
Adoptive transfer of NK cells engineered with a CD5-based chimeric antigen receptor (SRCD5CAR) to treat invasive fungal infectionsMaría Velasco-de-Andrés, Cristina Català, Laura Carrillo-Serradell, et al.
Allergologia Et Immunopathologia|February 2, 2021
Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approachesNatalia Egri, Ana Esteve-Solé, Àngela Deyà-Martínez, et al.
Seminars in Arthritis and Rheumatism|January 4, 2025
Rheumatologic complications of CAR-T Cell therapy. Experience of a single centerJosé A Gómez-Puerta, Ana Monegal, Andrés Ponce, et al.
Frontiers in Oncology|February 17, 2022
Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter's TransformationValentín Ortiz-Maldonado, Gerard Frigola, Marta Español-Rego, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2022
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 studyMarta Español-Rego, Carlos Fernández-Martos, Elena Elez, et al.
Pageof 4